Iterum Therapeutics plc - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ITRM Nasdaq 2830 www.iterumtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Iterum Therapeutics plc

Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jul 2nd, 2025 2:30 pm
Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth - Jun 30th, 2025 5:00 am
Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence - Jun 25th, 2025 5:00 am
Iterum Therapeutics Announces Partnership for Commercialization Services - Jun 11th, 2025 5:00 am
Iterum Therapeutics Announces Extension of Term of Promissory Note - May 19th, 2025 5:00 am
Iterum Therapeutics PLC (ITRM) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - May 14th, 2025 1:08 am
Iterum Therapeutics Reports First Quarter 2025 Financial Results - May 13th, 2025 5:00 am
Iterum Therapeutics plc (NASDAQ:ITRM): When Will It Breakeven? - May 10th, 2025 8:24 am
Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 - May 6th, 2025 5:00 am
Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares - Apr 30th, 2025 2:30 pm
Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares - Apr 29th, 2025 6:00 am
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics - Apr 14th, 2025 6:00 am
Iterum Therapeutics PLC (ITRM) Q4 2024 Earnings Call Highlights: Navigating Financial ... - Feb 8th, 2025 12:06 am
Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - Feb 7th, 2025 5:00 am
Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025 - Jan 31st, 2025 6:00 am
Iterum Therapeutics Regains Full Nasdaq Compliance - Nov 21st, 2024 6:30 am
Iterum Therapeutics PLC (ITRM) Q3 2024 Earnings Call Highlights: Strategic Moves Amid Financial ... - Nov 15th, 2024 12:10 am
Iterum Therapeutics Reports Third Quarter 2024 Financial Results - Nov 14th, 2024 5:00 am
Iterum Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024 - Nov 11th, 2024 6:00 am
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships - Oct 28th, 2024 8:19 am